Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BOD Members buy shares

As the pps tests new bottoms, that would be an appropriate action for BOD members who continue to reward themselves at undiminished compensation levels, to take. Not only to show confidence in the company they've stewarded to this point, but to make a statement to the market that the market has it wrong, AND to show alignment with their shareholders that they are serving SHAREHOLDER interests, and not specialized interests.

Until this BOD acts in ways that show what they state in PR's is what they believe, then, the market is correct to assume that what they state in PR's is simply covered by the CYA language at the bottom of each PR that essentially gives them an out.

LEADERS ACT through ACTION, not IN-action. Unfortunately, we've learned all too well PTSC is in dire need of LEADERS. Too bad no one had the foresight to see BOD changes a few years ago.

Share
New Message
Please login to post a reply